% | $
Quotes you view appear here for quick access.

Celgene Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • moridian moridian Jan 20, 1998 8:49 PM Flag

    CBM purchases Celgene Chiral Intermediat

    Celgene sold the rights because this was not their main area of focus & didn't expect this division to produce profits for many years. By selling it, CELG is able to focus on their drug pipeline & other divisions which have a more immediate potential return for the co. By selling this division celgene also reduces losses incurred by this division which should help a drop on the loss per share. The 7.5 Mill probably goes to earnings in 1998, which should make the P&L look better for '98.

    I have also heard that approval is expected on Thalidomide shortly. The rumor is probably related to the co. meeting with the FDA within the past 2 weeks

    SortNewest  |  Oldest  |  Most Replied Expand all replies
100.90-2.32(-2.25%)May 4 4:00 PMEDT